|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 90 No. 8 (October 15), 1997:
pp. 3089-3097
Defective Actin Reorganization and Polymerization of Wiskott-Aldrich T Cells in Response to CD3-Mediated Stimulation
By
María Dolores Gallego,
Manuel Santamaría,
José Peña, and
Ignacio J. Molina
From the Immunology Unit, University of Granada School of Medicine, Granada, Spain; and the Department of Physiology and Immunology, "Reina Sofía" University Hospital and School of Medicine, University of Córdoba, Córdoba, Spain.
 |
ABSTRACT |
The Wiskott-Aldrich syndrome (WAS) is a severe immunodeficiency and platelet deficiency disease arising from mutation(s) in the WASP gene, which in normal cells encodes an intracellular protein able to interact with other proteins relevant to the control of cytoskeleton organization. Immunodeficiency is mainly due to T-cell progressive malfunction. Salient defects of WAS T cells are a CD3-restricted impairment in proliferative responses and cytoskeletal abnormalities, including the frequent appearance of T cells with atypical morphology. We have investigated the possibility that the CD3-restricted defect and some of the cytoskeletal defects of WAS T cells are linked. For this purpose, we immortalized by means of infection with Herpesvirus Saimiri a number of previously described allospecific WAS T-cell lines. The resulting cells preserve the surface, molecular, and functional phenotypes of their parental lines, including a negligible WASP mRNA expression as well as the CD3-restricted defect and cytoskeleton abnormalities. Results show that, in CD3-stimulated WAS T cells, the pattern of temporal changes in cell shape and F-actin distribution is substantially different from that of control cells. Furthermore, polymerization of actin, a critical step in the CD3-mediated cytoskeleton reorganization, does not occur in WAS T-cell lines in response to OKT3 stimulation. In conclusion, our data link both CD3 and cytoskeletal defects in WAS T cells, strongly suggesting that cytoskeleton abnormalities are an underlying cause for WAS immunodeficiency.
| |
INTRODUCTION |
THE WISKOTT-ALDRICH syndrome (WAS) is a complex, X-linked multiorganic condition, with a typical presentation of eczema, a reduced number and size of platelets, and a progressive immunodeficiency (reviewed in Rosen et al1 and Remold-O'Donnell et al2 ). Well-known defects in WAS peripheral lymphocytes include alterations in the expression of CD433 as well as a paucity in the microvilli observed by scanning electron microscopy (SEM) on the cell surface.4 Antibody-production abnormalities are subsidiary to inefficient T-lymphocyte function.5 T lymphocytes are severely affected, playing a central role in the pathogenesis of the disease.2,5
Therefore, considerable effort has been devoted towards the characterization of the precise functional defect(s) present in WAS T lymphocytes. The establishment of allospecific T-cell lines allowed us to identify a number of pathogenic events in the WAS.6 We also showed that the lack of microvilli and the appearance of aberrant cellular forms are characteristic of the disease, because they reflect deep alterations in the organization of the cytoskeleton.6 This is supported by the molecular structure of the mutated gene recently found in WAS patients (WASP ).7 The gene comprises 12 exons giving rise to a protein (WASp) of 502 amino acids of unknown function,7,8 but several groups have recently shown that WASp binds to the small GTPase protein Cdc42,9,10 a member of the Rho family of proteins that play a critical role in the cytoskeleton organization.11-13
However, the precise function of WASp is still unclear, and although no direct evidence has been obtained so far, it has been proposed that WASp may act as a key intracellular switch in several signaling transmission pathways.9,14-16 In this sense, we are aware of the potential complexity of WASp, because, besides Cdc42, a number of regulatory proteins bind to concrete domains of WASp, including the SH3-adaptor protein Nck and the T-cell receptor (TCR)-associated protein tyrosin kinase p59fyn and Tec family members Btk, Itk, Tec, Grb2, and phospholipase C. In the WASp sequence, potential binding sites exist for additional regulatory proteins, including a pleckstrin-homology domain and actin-regulating protein homology sequences.17-22 All of these proteins have important regulatory functions involved in proliferation, signal transduction, and/or organization of the cytoskeleton.
All cell lines belonging to the WAS allospecific panel and peripheral lymphocytes of most patients share a functional deficiency: T cells are unable to proliferate in response to mitogenic anti-CD3 monoclonal antibodies (MoAbs).23 We report in this work a specific defect in reorganization and polymerization of actin in WAS cells when challenged with anti-CD3 MoAbs. Because anti-CD3 responses require a distinctive reorganization of actin filaments24 and induction of WASP gene expression results in the formation of aggregates of WASp and polymerized actin,9 our data strongly suggest that T-cell defect(s) of cytoskeleton organization is a primary cause underlying WAS immunodeficiency.
| |
MATERIALS AND METHODS |
Culture media.
For immortalization and culture of Herpesvirus Saimiri (HVS) Normal and WAS T-cell lines, a mixture (1:1) of RPMI 1640 (Bio-Whittaker, Verviers, Belgium) and CG (Serotec, Oxford, UK) was supplemented with 10% fetal calf serum, glutamine, penicillin-ampicillin, sodium pyruvate (all from Bio-Whittaker), 1 µmol/L 2-mercaptoethanol, and 50 UI/mL of human recombinant interleukin-2 (rIL-2; a generous gift of Hoffman-LaRoche, Nutley, NJ).
Antibodies.
All antibodies for flow cytometry were fluorescein isothiocyanate (FITC)-labeled and purchased from Becton Dickinson (San José, CA), with the following exceptions: anti-CD25, CD28, and CD45RO were from Immunotech (Marseille, France); and unlabeled anti-CD43 MoAbs L10 and T305 were a kind gift of Dr Eileen Remold-O'Donnell (The Center for Blood Research, Boston, MA). Anti-CD3 OKT3 hybridoma cells were obtained from the American Type Culture Collection (Rockville, MD). Secreted antibodies contained in culture supernatants were precipitated with ammonium sulfate and affinity-purified using the Affi-Gel Protein-A system (Bio-Rad Laboratories, Hercules, CA). Before use, all batches of purified OKT3 MoAb were titrated in flow cytometry and tested for mitogenicity over nylon-wool-purified human T cells.
View larger version (12K):
[in this window]
[in a new window]
| Fig 1.
Surface phenotype of prototypic HVS-Normal (HVS-N8) and HVS-WAS (HVS-WAS1) immortalized T-cell lines. Flow cytometric analysis shows that HVS-Normal and HVS-WAS T-cell lines have similar surface expression of CD2, CD3, CD4, CD25, CD28, and CD43 isoforms (MoAb L10 recognizes tetrasaccharide and hexasaccharide forms of CD43, whereas MoAb T305 reacts exclusively with the hexasaccharide isoform of the molecule), CD45, and HLA-DR. The two cell lines shown in the figure and all other cell lines obtained are CD56-.
|
|
Immortalization of T cells.
Normal and WAS T-cell lines were cultured as described,6 and 4 days before infection with HVS (kindly provided by Dr Bernhard Fleckenstein, University of Erlangen, Erlangen, Germany), cells were stimulated with the specific alloantigen expressed in the class II+ Raji B-cell line. At day 0, cells were washed, resuspended in RPMI/CG culture medium as indicated above, and cocultured with a 20% (vol/vol) fresh HVS crude supernatant produced in the epithelial owl monkey kidney cell line OMK as described.25,26 After an overnight incubation, cells were diluted with fresh media and expanded as required in 6-well plates (Nunc, Roskilde, Denmark), and 50% of media was replaced twice weekly. After 8 to 12 weeks, a steady growth of cells was evident and the cell line was considered immortalized. In all cases, HVS-immortalized T-cell lines remained dependent on the addition of exogenous IL-2 for continuous growth.
Flow cytometry.
Cultured cells were washed and incubated with the indicated FITC-labeled MoAbs on ice for 30 minutes, washed again, and analyzed in a FACSort flow cytometer (Becton Dickinson). Incubation with unlabeled anti-CD43 MoAbs was followed by a second step with a goat antimouse ( IgG) FITC-antibody (Tago, Burlingame, CA).
Reverse transcription-polymerase chain reaction (RT-PCR) of WASP.
Total RNA from HVS-Normal and HVS-WAS T-cell lines was extracted by the LiCl/urea method, and 4 µg of total RNA was reverse-transcribed using the AMV-Reverse transcription system (Promega, Madison, WI). Equal amounts of Normal and WAS cDNAs were amplified by PCR using 20-mers-specific primers deduced from the WASP sequence, spanning nucleotides 20-39 for the sense primer and 980-961 for the antisense primer. PCR amplification was performed in a Gene-Amp 9600 thermal cycler (Perkin-Elmer, Norwalk, CT) for 30 cycles with the following conditions: annealing at 60°C for 15 seconds, extension at 72°C for 75 seconds, and denaturing at 94°C for 20 seconds, with an initial denaturation of 2 minutes at 94°C and a final extension of 10 minutes at 72°C. Alliquots of PCR products were loaded onto 1.5% agarose gels and DNA stained with ethidium bromide.
Stimulation of cells.
For CD3-mediated stimulation of cells, 100 ng of purified OKT3 MoAb per well, unless otherwise indicated, was adsorbed overnight to the culture plate in phosphate-buffered saline (PBS), pH 8.0, at 37°C. Cells used in all experiments were washed the day before and starved overnight in RPMI/CG medium supplemented with 2% fetal calf serum and deprived of rIL-2.
View larger version (47K):
[in this window]
[in a new window]
| Fig 2.
WASP mRNA expression of HVS-Normal (HVS-N8) and HVS-WAS (HVS-WAS1) immortalized T-cell lines as detected by RT-PCR. Equal amounts of total RNA extracted from indicated cell lines were reverse-transcribed as detailed in the Materials and Methods. cDNAs were amplified by PCR using a pair of primers spanning WASP sequence nucleotides 20-39 (forward) and 980-961 (reverse). Amplification of HVS-Normal cells yields the expected fragment of 900 bp, whereas no equivalent band is detected in the HVS-WAS1 cells. In the last lane, the PCR-negative control (no template) was loaded.
|
|
Proliferation assay.
Proliferative responses of HVS-Normal and HVS-WAS immortalized T-cell lines were assessed as described.6,23 Briefly, T cells were harvested the day before the assay, washed, and cultured overnight in the absence of rIL-2. A total of 105 T cells per well were plated in a 96-well plate (Nunc) that had been precoated with the indicated amounts of OKT3 MoAb. Alternatively, cells were cocultured with different concentrations of Mitomycin-C-treated allospecific Raji cells. After 48 hours of culture, cells were labeled with 1 µCi/well of [3H]-thymidine (ICN, Costa Mesa, CA), the culture extended for an additional 16 hours and harvested and thymidine incorporation was finally quantified by liquid scintillation counting.
View larger version (18K):
[in this window]
[in a new window]
| Fig 3.
Proliferative responses of HVS-Normal (HVS-N8 [ ]) and HVS-WAS (HVS-WAS1 [ ] and HVS-WAS7 [ ]) immortalized T-cell lines after stimulation with immobilized OKT3 MoAb and allospecific Raji cells. Overnight-starved T cells were plated (105 cells/well) in 96-well plates that had been precoated with 10, 25, 50, or 100 ng/well of OKT3 MoAb (left panel) or cocultured in the presence of 25, 50, or 100 × 103 mitomycin-C treated allospecific Raji cells (right panel). After 48 hours of culture, cells were labeled with [3H]-thymidine for an additional 16 hours. Thymidine incorporation was determined by liquid scintillation counting.
|
|
SEM.
Exponentially grown cells were harvested from the culture and subjected to examination under the SEM as previously described for WAS T cells,6 with slight modifications. Briefly, Normal and WAS HVS-immortalized cells were washed in Ca2+/Mg2+-free PBS and allowed to bind to poly-l-lysine-coated slides simultaneously to the fixation process that was achieved during an overnight incubation at 4°C in an atmosphere saturated with glutaraldehyde vapors. Cells were postfixed in 1% osmium tetroxide for 1 hour, dehydrated with graded ethanols, subjected to critical point drying from carbon dioxide, and finally coated with gold. Samples were examined on a Zeiss DSM 950 Scanning electron microscope (Zeiss, Oberkochen, Germany).
Staining of filamentous actin.
For visualization of actin reorganization, 5 × 105 cells/well were stimulated with precoated OKT3 in 8-well chamber slides (Nunc). The reactions were stopped by fixing the cells in 2% paraformaldehyde (Sigma Chemical, St Louis, MO) for 30 minutes at room temperature. After washes with PBS, slides were incubated with tetramethilrodamine isothyocianate (TRITC)-labeled phalloidin (Molecular Probes, Eugene, OR; 1:50 dilution in PBS/0.05% saponin [Sigma]) for 40 minutes at room temperature. Cells were subsequently washed in PBS, the chambers were removed, and the slides were air-dried. Coverslips were mounted over 100 µL of a 1:1 solution of PBS/glycerol containing 10% water saturated with the antioxidant p-phenylene diamine (Sigma). Slides were viewed and photographed immediately. For the analysis by flow cytometry of CD3-induced actin polymerization, cells were stimulated in OKT3-coated 24-well plates as indicated above, fixed, and stained with rhodamine-phalloidin as before. After washes, cells were resuspended in PBS and analyzed after appropriate gating of cells in the FACSort flow cytometer. If saturating quantities of fluorescent phalloidin are used, then the fluorescence is a quantitative measure of the amount of filamentous actin in cells.27 Where indicated, cells were pretreated for 45 minutes at 37°C with 3 µmol/L cytochalasin D (Sigma) and stimulated with MoAbs immediately afterwards. Phalloidin is an agent that selectively binds to F-actin, whereas cytochalasin D binds to the barbed end of actin filaments, inhibiting both the association and dissociation of subunits at that end.27
| |
RESULTS |
Immortalization of WAS-allospecific T-cell lines by infection with HVS.
To improve our experimental system of allospecific T-cell lines, a number of Normal and WAS T-cell lines underwent selective immortalization by means of HVS infection.25,26 Immortalization was achieved 4 to 6 weeks after infection, when a vigorous pace of growth is observed in the infected cells. All of our HVS cell lines (WAS and Normal) remain stable after long-term culture and continue their dependence on the addition of exogenous IL-2 for continuous culture.
Surface phenotype of HVS-immortalized WAS and Normal T-cell lines.
Staining of cells with specific MoAbs showed by immunocytometric analysis a surface phenotype identical to that of their corresponding parental cell lines.6 This includes equivalent expression of CD2, CD3, CD4 or CD8, CD25, CD28, CD43 isoforms, CD45, and HLA-DR antigens (Fig 1). It has been described that HVS-immortalized T cells occasionally acquire the expression of CD56.25 All our cell lines are CD56-.
WASP mRNA expression in Normal and WAS HVS-immortalized T-cell lines.
Expression of WASP mRNA in Normal and WAS HVS-immortalized T-cell lines was studied by RT-PCR as detailed in the Materials and Methods. Amplification of the expected fragment of 900 bp was achieved in the HVS-Normal line, whereas no specific band was observed in the HVS-WAS T-cell line (Fig 2). Similar results were obtained using a different pair of internal WASP primers (data not shown).
Functional phenotype of HVS-WAS and HVS-Normal T-cell lines.
A restricted defect in the CD3-mediated proliferative response was identified in WAS peripheral lymphocytes and in the panel of allospecific WAS T-cell lines.23 To verify the fidelity of the functional phenotype of the HVS-immortalized T-cell lines, Normal and WAS T cells were challenged with immobilized anti-CD3 MoAb. The coupling of the CD3 complex by the OKT3 MoAb elicits a vigorous proliferative response in Normal, but not in WAS, HVS-immortalized cells (Fig 3, left panel). Both Normal and WAS lines strongly proliferate when stimulated with the specific alloantigen expressed in the Raji B-cell line (Fig 3, right panel). This pattern of responses precisely mirrors that of the untransformed parental T-cell lines, thereby indicating the functional preservation of the clonotypic TCR.
Surface morphology of T-cell lines.
As mentioned in the introduction, SEM analysis of WAS cells has been extensively used to substantiate cytoarchitectural defects.4,6 The examination of HVS-Normal T cells showed cell populations relatively homogeneous in size and morphology, and virtually all cells display the dense projection of surface microvilli characteristic of peripheral blood lymphocytes and allospecific T-cell lines obtained from normal individuals. Figure 4 shows random individual cells. In contrast, the size and morphology of the WAS T-cell lines are very heterogeneous, showing prominent defects. The previously observed cells with bulbous or lamellar forms are represented in Fig 5a and b. The cells with elongated and aberrant shapes are depicted in Fig 5c, d, and e. The described defects appear to be in the HVS-WAS cells more consistent and conspicuous than in the previously described long-term allospecific T-cell lines and/or WAS peripheral T cells.4,6
View larger version (136K):
[in this window]
[in a new window]
View larger version (173K):
[in this window]
[in a new window]
| Fig 4.
SEM of HVS-Normal (HVS-N8) T cells. Random individual cells of an HVS-immortalized T-cell line derived from a normal individual. Cells are homogeneous in size and morphology, displaying dense projections of surface microvilli that are typical of normal peripheral blood lymphocytes and allospecific normal T-cell lines. (Original magnification × 8,000.)
|
|
Differential CD3-dependent reorganization of actin filaments in HVS-WAS cells.
The coupling of the TCR/CD3 molecular complex triggers a distinct pattern of reorganization of the cellular F-actin.24,28 Therefore, we examined the response of the cytoskeleton after challenging with anti-CD3 MoAb HVS-Normal and HVS-WAS T-cell lines. In HVS-Normal cells, the actin reorganization in response to anti-CD3 stimulation is similar to that described for Jurkat cells.24 The early phase of the response (5 minutes) shows a diffuse distribution of the F-actin throughout the cytoplasm, with a reinforcement adjacent to the inner membrane of the cell that conforms the typical actin rings (Fig 6a). The remodeling of the actin cytoskeleton progresses with time, and spreading of cells is accompanied by the appearance of attachment pseudopods at 15 and 30 minutes after stimulation (Fig 6b and c).
View larger version (75K):
[in this window]
[in a new window]
View larger version (75K):
[in this window]
[in a new window]
View larger version (74K):
[in this window]
[in a new window]
View larger version (54K):
[in this window]
[in a new window]
View larger version (67K):
[in this window]
[in a new window]
View larger version (53K):
[in this window]
[in a new window]
View larger version (65K):
[in this window]
[in a new window]
View larger version (57K):
[in this window]
[in a new window]
| Fig 6.
Actin reorganization of HVS-Normal (HVS-N8 [a through d]) and HVS-WAS (HVS-WAS1 [e through h]) T-cell lines in response to stimulation with immobilized anti-CD3 MoAb. HVS-Normal (a through d) and HVS-WAS (e through h) T cells were stimulated with immobilized OKT3 MoAb for 5 minutes (a and e), 15 minutes (b and f ), and 30 minutes (c and g). In HVS-Normal cells, actin rings are progressively dissolved, followed by cellular spreading and frequent formation of pseudopodia. In contrast, in HVS-WAS T cells, actin rings yield to strongly polarized accumulations of F-actin. HVS-WAS T cells that fail to spread acquire atypical shapes with the appearance of structures resembling uropods. Pretreatment of cells with cytochalasin D abrogates all actin-specific changes in both HVS-Normal (d) and HVS-WAS (h) immortalized T cells. (Original magnification × 400, except for [d] and [h], which are ×630.)
|
|
In contrast, WAS cells show deep abnormalities in the pattern of actin reorganization. Thus, whereas in some cells actin rings are readily observed after 5 minutes of OKT3 stimulation (Fig 6e), in other cells the actin begins to cluster in a cellular pole. The striking polarization of F-actin becomes a generalized phenomena after 15 minutes of stimulation (Fig 6f and g). Simultaneously, cells display aberrant morphologies and are unable to undergo the process of spreading that is observed in the HVS-Normal cells. Pretreatment of cells with cytochalasin D prevents all CD3-mediated specific changes in cell shape (Fig 6d and h). At the same time, nonstimulating MoAbs do not induce any of the CD3-associated changes described above (data not shown).
Defective polymerization of actin in HVS-WAS cells in response to anti-CD3 challenge.
It is known that polymerization of actin is a critical step in the CD3-mediated cytoskeleton reorganization.24,28 Based on the described observations, we have examined the ability of HVS-Normal and HVS-WAS T-cell lines to form new actin filaments upon OKT3 engagement of the CD3/TCR complex. A rapid (5 minutes) polymerization of actin occurs in HVS-Normal cells as determined by phalloidin binding changes detected in flow cytometry (Fig 7). The fluorescence intensity increases until 30 minutes after stimulation, reflecting the kinetic of the process of actin polymerization, specifically abrogated after pretreatment of HVS-Normal cells with cytochalasin D. In sharp contrast, no differences were found in fluorescence staining intensity when OKT3-stimulated and nonstimulated HVS-WAS cells were compared, indicating that HVS-WAS cells are unable to polymerize actin in response to OKT3 challenge. Interestingly, stimulation of HVS-Normal and WAS cells with phorbol myristate acetate (PMA) does not induce new formation of actin filaments (data not shown). PMA induces polymerization of actin in resting peripheral lymphocytes,28 but has no effects on the Jurkat T-cell line.24
View larger version (23K):
[in this window]
[in a new window]
| Fig 7.
HVS-immortalized WAS T cells do not polymerize actin in response to stimulation with immobilized anti-CD3 MoAb. HVS-Normal (HVS-N8) and HVS-WAS (HVS-WAS1) cells were stimulated with immobilized anti-CD3 MoAb for indicated times, fixed, permeabilized, stained with Rhodamine-phalloidin, and finally analyzed by flow cytometry. Fluorescence profiles of stimulated (solid figures) and unstimulated (open figures, dotted lines) cells are overlayed. Thus, the negative control is set to represent the total amount of F-actin contained in unstimulated cells. The increase in the fluorescence intensity indicates a rapid passage from G-actin to F-actin in Normal cells in response to OKT3 (central column), a process that is specifically abrogated by pretreatment of cells with cytochalasin D (right column). HVS-WAS cells are unable to polymerize actin in response to OKT3 (left column).
|
|
| |
DISCUSSION |
Actin is a major cytoskeletal protein that is found in resting cells in two forms: a monomeric, globular form (G-actin) and a polymerized, filamentous form (F-actin). A critical step in the T-cell response to antigen and CD3-mediated stimulation is the polymerization of actin.24,29 Furthermore, activation of T cells with anti-CD3 MoAbs provokes a distinctive pattern of F-actin reordenation in the cell as well as characteristic changes in cell shape. This includes the progressive dissolution of actin rings, which is followed by cellular spreading and frequent formation of pseudopodia.24 Thus, we explored the possibility that actin reorganization abnormalities could provide a common ground for the previously reported defects in WAS T cells, namely the impaired CD3-mediated response and the morphologic defects.
The establishment of a panel of allospecific WAS T-cell lines has been a useful tool for dissecting functional defects present in WAS T lymphocytes. This included the re-evaluation of the biologic significance of the CD43 abnormalities and the finding of a restricted defect in CD3-mediated proliferative responses.6,23 The presence in the system of allostimulatory cells, which are needed for the growth of our T-cell lines, may hamper the interpretation of results that specifically concern to ubiquitous cellular components. Thus, pertaining to the present study, elimination of all non-T-cell elements would be desirable, provided that the resulting cells retain the morphologic, phenotypical, molecular, and functional properties of the parental cells from which they are derived. With this aim in mind, we have undertaken a novel approach in the field of primary immunodeficiencies, based on the immortalization of T cells with the HVS, a new world monkey virus that selectively infects human T cells in vitro.25,26
The results obtained in this work show that all HVS-Normal and HVS-WAS T cells are faithful counterparts of their parental lines, because they have a surface phenotype that is identical to that of the cell lines from which they are derived. The distinctive pattern of responses is also preserved, as determined by the proliferative responses to allospecific stimulatory cells and to anti-CD3 MoAbs. In addition, examination of HVS-WAS T-cell lines under SEM shows conspicuous morphologic abnormalities that are typical to WAS T cells, such as the lack of microvilli from the membrane and the presence of aberrant cellular forms.6 Therefore, our results show the adequacy of HVS-immortalization as a valid experimental approach to study, in the absence of other cell types, intrinsic T-cell abnormalities in WAS and other immunodeficiencies.
The stimulation with anti-CD3 MoAb of the HVS-Normal and WAS T cells shows striking defects in the latter. First, HVS-WAS T cells retain the CD3-restricted defect in proliferative response. Second, the changes in actin reorganization and cell shape that follows OKT3 stimulation of HVS-Normal T cells are not observed in HVS-WAS T cells. Indeed, in HVS-WAS T cells, actin rings yield to strongly polarized accumulations of F-actin. HVS-WAS T cells, which fail to spread, acquire atypical shapes with the appearance of structures resembling uropods. Third, in HVS-Normal cells, OKT3 binding gives rise to a rapid passage from G-actin to F-actin, as shown in flow cytometry by the increased staining of cells with TRITC-phalloidin. Strikingly, the CD3-induced actin polymerization is not detectable in HVS-WAS cells, because Rhodamine-phalloidin staining intensity is the same in stimulated and nonstimulated cells in all timepoints studied.
An immediate implication of this finding is that the abnormal pattern of actin reorganization in the HVS-WAS cells occurs exclusively at the expenses of the F-actin existing in the cell before stimulation. In fact, WASp, which is deficient in HVS-WAS T cells, putatively binds actin through regions on its carboxy-terminal end with some structural similarities to known actin-regulating proteins. Consequently, the possibility that WASp plays a direct role in the process of polymerization of actin from the globular to the filamentous form has to be considered. Supporting this idea is the fact that, in genetically altered WASp-overexpressing cells, the protein colocalizes with polymerized actin in the cytoplasm, in an interaction that is regulated by Cdc42.9
In this context, WAS can be seen as a natural knock-out model of WASP, and our data indicate that the product of this gene has a critical role in cytoskeleton reordenation events. Other potential functions of WASp are suggested by its capacity to bind a number of SH3-proteins (ie, p59fyn, Nck, etc) mainly involved in transmission of activation and proliferation signals. Because WAS T cells (parental and immortalized) do proliferate, the participation of WASp in controlling cell proliferation could be either a negative regulatory role or otherwise a dispensable function.
As a corollary, our data raise some clues for deciphering the intriguing WAS paradox, namely the coexistence of a defective CD3-mediated intracellular signaling with a normal allogeneic response. In this regard, it has been shown that Cdc42 is responsible for the cytoskeletal remodeling leading to polarization of T cells toward the direction of a external signal, delivered by antigen-presenting cells in specific responses.29 However, it remains unknown whether the same occurs during T-lymphocyte allorecognition. Thus, a possibility to consider is that, in WASp-deficient cells at least, CD3-transduced extracellular signals proceed to the cytoplasm following an intracellular route in which WASp is a checkpoint. Accordingly, in the alloresponse, in which a number of ligand-receptor pair interactions occur, productive cytoskeleton rearrangement would be controlled by alternative pathways that are able to replace WASp function. This hypothesis would also explain the unusually high rate of rejection of haploidentical grafts in bone marrow transplanted WAS patients.30-33
A number of issues regarding the precise role of WASp in the regulation of T-cell function still remain unresolved. Nevertheless, our data provide the first evidence of a direct connection between two relevant defects of WAS T cells, namely the CD3-restricted defect and actin reorganization abnormalities, strongly suggesting that an underlying cause for WAS immunodeficiency is an anomalous cytoskeleton structure.
| |
FOOTNOTES |
Submitted April 2, 1997;
accepted June 6, 1997.
Supported by Grant No. PB94-0753 from the DGICYT of the Spanish Ministry of Education and Science and Grant No. FIS 95-1170 from the Fondo de Investigaciones Sanitarias. M.D.G. is a predoctoral fellow of the Spanish Ministry of Education.
Address reprint requests to Manuel Santamaría, MD, Departamento de Fisiología e Inmunología, Facultad de Medicina, Avda. Menéndez Pidal s/n, E-14004 Córdoba, Spain.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be hearly marked
``advertisment'' in accordance with 18 U.S.C. section 1734 solely to
indicate this fact.
| |
ACKNOWLEDGMENT |
The authors are indebted to Dr Juan M. Millán for help with the infection and establishment of HVS-immortalized T-cell lines; to Alicia González and Concha Hernández (Centro de Instrumentación Científica of the University of Granada, Granada, Spain) for expert assistance with scanning electron microscopy techniques; to Dr Bernhard Fleckenstein for providing us with the Herpesvirus Saimiri and the OMK cells; to Hoffman-LaRoche for their generous gift of human rIL-2; and to Dr Eileen Remold-O'Donnell for reagents and help.
| |
REFERENCES |
1.
Rosen FS,
Cooper MD,
Wedgwood RJP:
Medical progress  The primary immunodeficiencies.
N Engl J Med
333:431,
1995[Free Full Text]
2.
Remold-O'Donnell E,
Rosen FS,
Kenney DM:
Defects in Wiskott-Aldrich syndrome blood cells.
Blood
87:2621,
1996[Free Full Text]
3.
Remold-O'Donnell E,
Kenney DM,
Parkman R,
Cairns L,
Savage B,
Rosen FS:
Characterization of a human lymphocyte surface glycoprotein that is defective in Wiskott-Aldrich Syndrome.
J Exp Med
159:1705,
1984[Abstract/Free Full Text]
4.
Kenney D,
Cairns L,
Remold-O'Donnell E,
Peterson J,
Rosen FS,
Parkman R:
Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome.
Blood
68:1329,
1986[Abstract/Free Full Text]
5.
Parkman R,
Rappeport J,
Geha R,
Belli J,
Cassady R,
Levey R,
Nathan DG,
Rosen FS:
Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.
N Engl J Med
298:921,
1978[Abstract]
6.
Molina IJ,
Kenney DM,
Rosen FS,
Remold-O'Donnell E:
T cell lines characterize events in the Wiskott-Aldrich syndrome.
J Exp Med
176:867,
1992[Abstract/Free Full Text]
7.
Derry JMJ,
Ochs H,
Francke U:
Isolation of a novel gene mutated in Wiskott-Aldrich syndrome.
Cell
78:635,
1994[Medline]
[Order article via Infotrieve]
8. Kwan SP, Hagemann TL, Radtke BE, Blaese RM, Rosen FS: Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at Dxs6940, adjacent to the disease gene. Proc Natl Acad Sci USA 92:4706 1995
9.
Symons M,
Derry JMJ,
Karlak B,
Jiang S,
Lemahieu V,
McCormick F,
Francke U,
Abo A:
Wiskott-Aldrich syndrome protein, a novel effector for the GTPase Cdc42Hs, is implicated in actin polymerization.
Cell
84:723,
1996[Medline]
[Order article via Infotrieve]
10.
Kolluri R,
Tolias KF,
Carpenter CL,
Rosen FS,
Kirchhausen T:
Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42.
Proc Natl Acad Sci USA
93:5615,
1996[Abstract/Free Full Text]
11.
Ridley AJ,
Hall A:
The Small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors.
Cell
70:389,
1992[Medline]
[Order article via Infotrieve]
12.
Ridley AJ,
Paterson CL,
Johnston D,
Diekmann D,
Hall A:
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling.
Cell
70:401,
1992[Medline]
[Order article via Infotrieve]
13.
Nobes CD,
Hall A:
Rho, Rac and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with stress fibers, lamellipodia and filopodia.
Cell
81:53,
1995[Medline]
[Order article via Infotrieve]
14.
Rosen FS:
The enigma of the Wiskott-Aldrich syndrome begins to unravel.
J Clin Invest
97:2407,
1996[Medline]
[Order article via Infotrieve]
15.
Kirchhausen T,
Rosen FS:
Disease mechanism: Unravelling Wiskott-Aldrich syndrome.
Curr Biol
6:676,
1996[Medline]
[Order article via Infotrieve]
16.
Featherstone C:
The many faces of WAS protein.
Science
275:27,
1997[Free Full Text]
17.
Rivero-Lezcano OM,
Marcilla A,
Sameshima JH,
Robbins KC:
Wiskott-Aldrich syndrome protein physically associates with Nck through SRC homology-3 domains.
Mol Cell Biol
15:5725,
1995[Abstract]
18.
Cory GO,
MacCarthy-Morrogh L,
Banin S,
Brickell PM,
Levinsky RJ,
Kinnon C,
Lovering RC:
Evidence that the Wiskott-Aldrich syndrome protein may be involved in cell signalling pathways.
J Immunol
157:3791,
1996[Abstract]
19.
Bunnell SC,
Henry PA,
Kolluri R,
Kirchhausen T,
Rickles RJ,
Berg LJ:
Identification of Itk/Tsk Src homology 3 domain ligands.
J Biol Chem
271:25646,
1996[Abstract/Free Full Text]
20.
Finan PM,
Soames CJ,
Wilson L,
Nelson DL,
Stewart DM,
Truong O,
Hsuan JJ,
Kellie S:
Identification of regions of the Wiskott-Aldrich syndrome protein responsible for association with selected Src homology 3 domains.
J Biol Chem
271:26291,
1996[Abstract/Free Full Text]
21.
Quillian LA,
Lambert L,
Mickelson-Young LA,
Westwick JK,
Sparks AB,
Kay BK,
Jenkins NA,
Gilbert DJ,
Copeland NG,
Der CJ:
Isolation of a NCK-associated kinase, PKR2, an SH3-binding protein and potential effector of Rho protein signaling.
J Biol Chem
271:28772,
1996[Abstract/Free Full Text]
22.
Banin S,
Truong O,
Katz DR,
Waterfield MD,
Brickell PM,
Gout I:
Wiskott-Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases.
Curr Biol
6:981,
1996[Medline]
[Order article via Infotrieve]
23.
Molina IJ,
Sancho C,
Terhorst C,
Rosen FS,
Remold-O'Donnell E:
T-cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses.
J Immunol
151:4383,
1993[Abstract]
24.
Parsey MV,
Lewis GK:
Actin polymerization and pseudopod reorganization accompany anti-CD3-induced growth arrest in Jurkat T cells.
J Immunol
151:1881,
1993[Abstract]
25.
Meinl E,
Hohlfeld R,
Wekerle H,
Fleckenstein B:
Immortalization of human T-cells by Herpesvirus-Saimiri.
Immunol Today
16:55,
1995[Medline]
[Order article via Infotrieve]
26.
Biesinger B,
Müller-Fleckenstein I,
Simmer B,
Lang G,
Wittman S,
Platzer E,
Desrosiers RC,
Fleckenstein B:
Stable growth transformation of human T lymphocytes by Herpesvirus saimiri.
Proc Natl Acad Sci USA
89:3116,
1992[Abstract/Free Full Text]
27.
Cooper JA:
Effects of cytochalasin and phalloidin on actin.
J Cell Biol
105:1473,
1987[Free Full Text]
28.
Pardi R,
Inverardi C,
Rugarli C,
Bender JR:
Antigen-receptor complex stimulation triggers protein kinase C-dependent CD11a/CD18-cytoskeleton association in T lymphocytes.
J Cell Biol
116:1211,
1992[Abstract/Free Full Text]
29.
Stowers L,
Yelon D,
Berg LJ,
Chant J:
Regulation of the polarization of T cells toward antigen-presenting cells by Ras-related GTPase CDC42.
Proc Natl Acad Sci USA
92:5027,
1995[Abstract/Free Full Text]
30.
Rumelhart S L,
Trigg ME,
Horowitz SD,
Hong R:
Monoclonal antibody T-cell-depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome.
Blood
75:1031,
1990[Abstract/Free Full Text]
31.
Mullen CA,
Anderson KD,
Blaese RM:
Splenectomy and or bone-marrow transplantation in the management of the Wiskott-Aldrich syndrome Long-term follow-up of 62 cases.
Blood
82:2961,
1993[Abstract/Free Full Text]
32.
Lenarsky C,
Weinberg K,
Kohn DB,
Parkman R:
Unrelated donor BMT for Wiskott-Aldrich syndrome.
Bone Marrow Transplant
12:145,
1993[Medline]
[Order article via Infotrieve]
33.
Fischer A,
Landais P,
Friedrich W,
Gerritsen B,
Fasth A,
Porta A,
Vellodi A,
Benkerrou M,
Jais JP,
Cavazzanacalvo M,
Souillet G,
Bordigoni P,
Morgan G,
Vandijken P,
Vossen J,
Locatelli F,
Dibartolomeo P:
Bone-marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency A report from the European Group for BMT and the European Group for Immunodeficiency.
Blood
83:1149,
1994[Abstract/Free Full Text]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Bosticardo, F. Marangoni, A. Aiuti, A. Villa, and M. Grazia Roncarolo
Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome
Blood,
June 18, 2009;
113(25):
6288 - 6295.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Le Bras, M. Massaad, S. Koduru, L. Kumar, M. K. Oyoshi, J. Hartwig, and R. S. Geha
WIP is critical for T cell responsiveness to IL-2
PNAS,
May 5, 2009;
106(18):
7519 - 7524.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Meyer-Bahlburg, S. Becker-Herman, S. Humblet-Baron, S. Khim, M. Weber, G. Bouma, A. J. Thrasher, F. D. Batista, and D. J. Rawlings
Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis
Blood,
November 15, 2008;
112(10):
4158 - 4169.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I-J. Chen, H.-L. Chen, and M. Demetriou
Lateral Compartmentalization of T Cell Receptor Versus CD45 by Galectin-N-Glycan Binding and Microfilaments Coordinate Basal and Activation Signaling
J. Biol. Chem.,
November 30, 2007;
282(48):
35361 - 35372.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Badour, M. K. H. McGavin, J. Zhang, S. Freeman, C. Vieira, D. Filipp, M. Julius, G. B. Mills, and K. A. Siminovitch
Interaction of the Wiskott-Aldrich syndrome protein with sorting nexin 9 is required for CD28 endocytosis and cosignaling in T cells
PNAS,
January 30, 2007;
104(5):
1593 - 1598.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. de la Fuente, Y. Sasahara, M. Calamito, I. M. Anton, A. Elkhal, M. D. Gallego, K. Suresh, K. Siminovitch, H. D. Ochs, K. C. Anderson, et al.
WIP is a chaperone for Wiskott-Aldrich syndrome protein (WASP)
PNAS,
January 16, 2007;
104(3):
926 - 931.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. D. Gallego, M. A. de la Fuente, I. M. Anton, S. Snapper, R. Fuhlbrigge, and R. S. Geha
WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1{alpha}
Int. Immunol.,
February 1, 2006;
18(2):
221 - 232.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Wada, S. H. Schurman, E. K. Garabedian, A. Yachie, and F. Candotti
Analysis of T-cell repertoire diversity in Wiskott-Aldrich syndrome
Blood,
December 1, 2005;
106(12):
3895 - 3897.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Paccani, M. Boncristiano, L. Patrussi, C. Ulivieri, A. Wack, S. Valensin, T. R. Hirst, A. Amedei, G. del Prete, J. L. Telford, et al.
Defective Vav expression and impaired F-actin reorganization in a subset of patients with common variable immunodeficiency characterized by T-cell defects
Blood,
July 15, 2005;
106(2):
626 - 634.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Martin-Fernandez, J. A. Cabanillas, M. Rivero-Carmena, E. Lacasa, J. Pardo, A. Anel, P. R. Ramirez-Duque, F. Merino, C. Rodriguez-Gallego, and J. R. Regueiro
Herpesvirus saimiri-transformed CD8+ T cells as a tool to study Chediak-Higashi syndrome cytolytic lymphocytes
J. Leukoc. Biol.,
May 1, 2005;
77(5):
661 - 668.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Guerra, M. Aracil, R. Conde, A. Bernad, and M. Esteban
Wiskott-Aldrich Syndrome Protein Is Needed for Vaccinia Virus Pathogenesis
J. Virol.,
February 15, 2005;
79(4):
2133 - 2140.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Westerberg, M. Larsson, S. J. Hardy, C. Fernandez, A. J. Thrasher, and E. Severinson
Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response
Blood,
February 1, 2005;
105(3):
1144 - 1152.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Burns, G. O. Cory, W. Vainchenker, and A. J. Thrasher
Mechanisms of WASp-mediated hematologic and immunologic disease
Blood,
December 1, 2004;
104(12):
3454 - 3462.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Majstoravich, J. Zhang, S. Nicholson-Dykstra, S. Linder, W. Friedrich, K. A. Siminovitch, and H. N. Higgs
Lymphocyte microvilli are dynamic, actin-dependent structures that do not require Wiskott-Aldrich syndrome protein (WASp) for their morphology
Blood,
September 1, 2004;
104(5):
1396 - 1403.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Sorokina, J. J. Merlo Jr., and A. Y. Tsygankov
Molecular Mechanisms of the Effect of Herpesvirus saimiri Protein StpC on the Signaling Pathway Leading to NF-{kappa}B Activation
J. Biol. Chem.,
April 2, 2004;
279(14):
13469 - 13477.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Kettner, L. Kumar, I. M. Anton, Y. Sasahara, M. de la Fuente, V. I. Pivniouk, H. Falet, J. H. Hartwig, and R. S. Geha
WIP Regulates Signaling via the High Affinity Receptor for Immunoglobulin E in Mast Cells
J. Exp. Med.,
February 2, 2004;
199(3):
357 - 368.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Greicius, L. Westerberg, E. J. Davey, E. Buentke, A. Scheynius, J. Thyberg, and E. Severinson
Microvilli structures on B lymphocytes: inducible functional domains?
Int. Immunol.,
February 1, 2004;
16(2):
353 - 364.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Zeng, J. L. Cannon, R. T. Abraham, M. Way, D. D. Billadeau, J. Bubeck-Wardenberg, and J. K. Burkhardt
SLP-76 Coordinates Nck-Dependent Wiskott-Aldrich Syndrome Protein Recruitment with Vav-1/Cdc42-Dependent Wiskott-Aldrich Syndrome Protein Activation at the T Cell-APC Contact Site
J. Immunol.,
August 1, 2003;
171(3):
1360 - 1368.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Klein, D. Nguyen, C.-H. Liu, A. Mizoguchi, A. K. Bhan, H. Miki, T. Takenawa, F. S. Rosen, F. W. Alt, R. C. Mulligan, et al.
Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice
Blood,
March 15, 2003;
101(6):
2159 - 2166.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. O. C. Cory, R. Garg, R. Cramer, and A. J. Ridley
Phosphorylation of Tyrosine 291 Enhances the Ability of WASp to Stimulate Actin Polymerization and Filopodium Formation
J. Biol. Chem.,
November 15, 2002;
277(47):
45115 - 45121.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Yamaguchi, T. Ariga, M. Yamada, D. L. Nelson, R. Kobayashi, C. Kobayashi, Y. Noguchi, Y. Ito, K. Katamura, Y. Nagatoshi, et al.
Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation: evaluation by flow cytometric analysis of intracellular WAS protein expression
Blood,
July 30, 2002;
100(4):
1208 - 1214.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Sato, N. M. Tsuji, H. Gotoh, K. Yamashita, K. Hashimoto, N. Tadotsu, H. Yamanaka, K. Sekikawa, and Y. Hashimoto
Overexpression of the Wiskott-Aldrich Syndrome Protein N-Terminal Domain in Transgenic Mice Inhibits T Cell Proliferative Responses Via TCR Signaling Without Affecting Cytoskeletal Rearrangements
J. Immunol.,
October 15, 2001;
167(8):
4701 - 4709.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Westerberg, G. Greicius, S. B. Snapper, P. Aspenstrom, and E. Severinson
Cdc42, Rac1, and the Wiskott-Aldrich syndrome protein are involved in the cytoskeletal regulation of B lymphocytes
Blood,
August 15, 2001;
98(4):
1086 - 1094.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Rivero-Carmena, O. Porras, B. Pelaez, A. Pacheco-Castro, R. A. Gatti, and J. R. Regueiro
Membrane and transmembrane signaling in Herpesvirus saimiri-transformed human CD4+ and CD8+ T lymphocytes is ATM-independent.
Int. Immunol.,
June 1, 2000;
12(6):
927 - 935.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Wang, H. Zhang, P. A. Solski, M. J. Hart, C. J. Der, and L. Su
Modulation of HIV-1 Replication by a Novel RhoA Effector Activity
J. Immunol.,
May 15, 2000;
164(10):
5369 - 5374.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Krause, A. S. Sechi, M. Konradt, D. Monner, F. B. Gertler, and J. Wehland
Fyn-Binding Protein (Fyb)/Slp-76-Associated Protein (Slap), Ena/Vasodilator-Stimulated Phosphoprotein (Vasp) Proteins and the Arp2/3 Complex Link T Cell Receptor (Tcr) Signaling to the Actin Cytoskeleton
J. Cell Biol.,
April 3, 2000;
149(1):
181 - 194.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. N. Savoy, D. D. Billadeau, and P. J. Leibson
Cutting Edge: WIP, a Binding Partner for Wiskott-Aldrich Syndrome Protein, Cooperates with Vav in the Regulation of T Cell Activation
J. Immunol.,
March 15, 2000;
164(6):
2866 - 2870.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Tian, D. L. Nelson, and D. M. Stewart
Cdc42-interacting Protein 4 Mediates Binding of the Wiskott-Aldrich Syndrome Protein to Microtubules
J. Biol. Chem.,
March 10, 2000;
275(11):
7854 - 7861.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Rengan, H. D. Ochs, L. I. Sweet, M. L. Keil, W. T. Gunning, N. A. Lachant, L. A. Boxer, and G. M. Omann
Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells
Blood,
February 15, 2000;
95(4):
1283 - 1292.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M Jones and H. B Gaspar
Immunogenetics: changing the face of immunodeficiency
J. Clin. Pathol.,
January 1, 2000;
53(1):
60 - 65.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Shcherbina, F. S. Rosen, and E. Remold-O'Donnell
WASP Levels in Platelets and Lymphocytes of Wiskott-Aldrich Syndrome Patients Correlate with Cell Dysfunction
J. Immunol.,
December 1, 1999;
163(11):
6314 - 6320.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. L. Rawlings, G. M. Crooks, D. Bockstoce, L. W. Barsky, R. Parkman, and K. I. Weinberg
Spontaneous Apoptosis in Lymphocytes From Patients With Wiskott-Aldrich Syndrome: Correlation of Accelerated Cell Death and Attenuated Bcl-2 Expression
Blood,
December 1, 1999;
94(11):
3872 - 3882.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Zhang, A. Shehabeldin, L. A.G. da Cruz, J. Butler, A.-K. Somani, M. McGavin, I. Kozieradzki, A. O. dos Santos, A. Nagy, S. Grinstein, et al.
Antigen Receptor-Induced Activation and Cytoskeletal Rearrangement Are Impaired in Wiskott-Aldrich Syndrome Protein-Deficient Lymphocytes
J. Exp. Med.,
November 1, 1999;
190(9):
1329 - 1342.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Ohashi, S. Iwata, K. Kamiguchi, and C. Morimoto
Tyrosine Phosphorylation of Crk-Associated Substrate Lymphocyte-Type Is a Critical Element in TCR- and {beta}1 Integrin-Induced T Lymphocyte Migration
J. Immunol.,
October 1, 1999;
163(7):
3727 - 3734.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Linder, D. Nelson, , M. Weiss, and M. Aepfelbacher
Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages
PNAS,
August 17, 1999;
96(17):
9648 - 9653.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Haddad, E. Cramer, C. Riviere, P. Rameau, F. Louache, J. Guichard, D. L. Nelson, A. Fischer, W. Vainchenker, and N. Debili
The Thrombocytopenia of Wiskott Aldrich Syndrome Is Not Related to a Defect in Proplatelet Formation
Blood,
July 15, 1999;
94(2):
509 - 518.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Vaduva, N. Martinez-Quiles, I. M. Anton, N. C. Martin, R. S. Geha, A. K. Hopper, and N. Ramesh
The Human WASP-interacting Protein, WIP, Activates the Cell Polarity Pathway in Yeast
J. Biol. Chem.,
June 11, 1999;
274(24):
17103 - 17108.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. Stewart, L. Tian, and D. L. Nelson
Mutations That Cause the Wiskott-Aldrich Syndrome Impair the Interaction of Wiskott-Aldrich Syndrome Protein (WASP) with WASP Interacting Protein
J. Immunol.,
April 15, 1999;
162(8):
5019 - 5024.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T.S. FINCO, D. YABLONSKI, J. LIN, and A. WEISS
The Adapter Proteins LAT and SLP-76 Are Required for T-cell Activation
Cold Spring Harb Symp Quant Biol,
January 1, 1999;
64(0):
265 - 274.
[Abstract]
[PDF]
|
|
|
|
|
|
|
Y. Wu, D. Dowbenko, and L. A. Lasky
PSTPIP 2, a Second Tyrosine Phosphorylated, Cytoskeletal-associated Protein That Binds a PEST-type Protein-tyrosine Phosphatase
J. Biol. Chem.,
November 13, 1998;
273(46):
30487 - 30496.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Pacheco-Castro, D. Alvarez-Zapata, P. Serrano-Torres, and J. R. Regueiro
Signaling Through a CD3{gamma}-Deficient TCR/CD3 Complex in Immortalized Mature CD4+ and CD8+ T Lymphocytes
J. Immunol.,
September 15, 1998;
161(6):
3152 - 3160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Oda, H. D. Ochs, B. J. Druker, K. Ozaki, C. Watanabe, M. Handa, Y. Miyakawa, and Y. Ikeda
Collagen Induces Tyrosine Phosphorylation of Wiskott-Aldrich Syndrome Protein in Human Platelets
Blood,
September 15, 1998;
92(6):
1852 - 1858.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Bear, J. F. Rawls, and C. L. Saxe III
SCAR, a WASP-related Protein, Isolated as a Suppressor of Receptor Defects in Late Dictyostelium Development
J. Cell Biol.,
September 7, 1998;
142(5):
1325 - 1335.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
Abstract
Introduction
Abstract
